China Cord Blood Corp. (CO) Hits New 1-Year Low at $5.25
China Cord Blood Corp. (NYSE:CO) hit a new 52-week low on Wednesday . The stock traded as low as $5.25 and last traded at $5.25, with a volume of 23,600 shares traded. The stock had previously closed at $5.30.
CO has been the subject of several research reports. Zacks Investment Research cut China Cord Blood Corp. from a “hold” rating to a “sell” rating in a report on Tuesday, July 19th. TheStreet cut China Cord Blood Corp. from a “buy” rating to a “hold” rating in a research note on Thursday, August 4th. Five research analysts have rated the stock with a hold rating and one has assigned a buy rating to the stock. The company currently has a consensus rating of “Hold” and an average target price of $7.00.
The company has a market capitalization of $407.62 million and a PE ratio of 27.07. The firm has a 50 day moving average price of $5.50 and a 200 day moving average price of $5.90.
China Cord Blood Corp. (NYSE:CO) last announced its quarterly earnings data on Tuesday, June 14th. The company reported $0.03 EPS for the quarter, hitting the Zacks’ consensus estimate of $0.03. The company had revenue of $24.30 million for the quarter. On average, equities analysts anticipate that China Cord Blood Corp. will post $0.17 earnings per share for the current fiscal year.
China Cord Blood Corporation is principally engaged in the provision of umbilical cord blood storage and ancillary services in the People’s Republic of China. The Company provides cord blood testing, processing and storage services under the direction of subscribers. The Company also preserves cord blood units donated by the public, provides matching services on such donated units and delivers matching units to patients in need of transplants.
Get Analysts' Upgrades and Downgrades Daily - Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.